3
total announcements
SUDARSHAN.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 31 Oct 2026
P/E (TTM)
35.0
EPS (TTM)
₹1.04
52W Low
₹34.66
52W High
₹39.30
Dividend Yield
0.00%
Beta
0.85
Price / Book
5.7
Debt / Equity
182.3
Revenue (TTM)
₹732 Cr
Gross Margin
12.61%
Operating Margin
8.31%
Sudarshan Pharma Industries Limited
Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities - The Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising of funds through issue and allotment of Convertible Warrants upto an amount not exceeding Rs.72 Crores to Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company.
Sudarshan Pharma Industries Limited
Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities, specifically the proposal to raise funds through the issue and allotment of up to 72,00,00,000 warrants convertible into equity shares at a price to be determined, subject to regulatory approvals and shareholder approval at an EGM.
Sudarshan Pharma Industries Limited
Sudarshan Pharma Industries Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended 30th September, 2026. The results show a total income of ₹2,68,61.17, expenses of ₹19,59,282.82, and a profit before tax of ₹1,09,3.35. The company's basic EPS is ₹0.25 and diluted EPS is ₹0.16.